News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Day One Biopharmaceuticals announces a new ex-U.S. licensing agreement with Ipsen to commercialize tovorafenib
Photo from Day One Biopharmaceuticals/LinkedIn
Jul 27, 2024, 22:01

Day One Biopharmaceuticals announces a new ex-U.S. licensing agreement with Ipsen to commercialize tovorafenib

Day One Biopharmaceuticals shared a post on LinkedIn:

”We are pleased to announce a new ex-U.S. licensing agreement with Ipsen to commercialize tovorafenib. This collaboration highlights our shared commitment to bring novel therapeutics to patients worldwide who have limited treatment options. Learn more.”

Source: Day One Biopharmaceuticals/LinkedIn

cancer cancer treatment Day One Biopharmaceuticals Ipsen OncoDaily Oncology tovorafenib
Insight
Jul 27, 2024, 22:17
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy - Weill Cornell Medicine
Insight
Jul 27, 2024, 22:17
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Blog
Jul 27, 2024, 22:07
Maria Bourlon: iPARPs in prostate cancer
Blog
Jul 27, 2024, 22:06
ESH Lymphoma 2024 program highlight: Rountable 1
Blog
Jul 27, 2024, 22:06
Lung cancer diagnostics in discuss the latest insights and guidelines with Anne Schultheis at ILCS24 - International Lung Cancer Summit
Blog
Jul 27, 2024, 22:06
Codex Genetics's Annual Oncology Roundtable: Tackling Minimal Residual Disease and Complex Mutations
Blog
Jul 27, 2024, 22:05
Another unique Chai For Cancer by Madhavi Pal in support of her best friend recovering from a cancer diagnosis
Blog
Jul 27, 2024, 22:05
Carnell Jermaine Hampton: My first ever 'speed mentoring' event at Atrium Health Levine Cancer
Blog
Jul 27, 2024, 22:05
When should you get screened for cancer- St. Elizabeth Healthcare
Blog
Jul 27, 2024, 22:01
Day One Biopharmaceuticals announces a new ex-U.S. licensing agreement with Ipsen to commercialize tovorafenib
Blog
Jul 27, 2024, 22:01
Shannon Rutledge joins St. Baldrick's Foundation Board of Directors
Blog
Jul 27, 2024, 22:00
The International PhD Student Cancer Conference - Manchester Cancer Research Centre